Oxidative stress in prostate cancer
- PMID: 19185987
- PMCID: PMC2789743
- DOI: 10.1016/j.canlet.2008.12.011
Oxidative stress in prostate cancer
Abstract
As prostate cancer and aberrant changes in reactive oxygen species (ROS) become more common with aging, ROS signaling may play an important role in the development and progression of this malignancy. Increased ROS, otherwise known as oxidative stress, is a result of either increased ROS generation or a loss of antioxidant defense mechanisms. Oxidative stress is associated with several pathological conditions including inflammation and infection. ROS are products of normal cellular metabolism and play vital roles in stimulation of signaling pathways in response to changing intra- and extracellular environmental conditions. Chronic increases in ROS over time are known to induce somatic mutations and neoplastic transformation. In this review we summarize the causes for increased ROS generation and its potential role in etiology and progression of prostate cancer.
Conflict of interest statement
None Decalred
Figures
Similar articles
-
ROS Generation and Antioxidant Defense Systems in Normal and Malignant Cells.Oxid Med Cell Longev. 2019 Aug 5;2019:6175804. doi: 10.1155/2019/6175804. eCollection 2019. Oxid Med Cell Longev. 2019. PMID: 31467634 Free PMC article. Review.
-
The role of oxidative stress in prostate cancer.Eur J Cancer Prev. 2012 Mar;21(2):155-62. doi: 10.1097/CEJ.0b013e32834a8002. Eur J Cancer Prev. 2012. PMID: 21857523 Review.
-
Oxidative stress-related aging: A role for prostate cancer?Biochim Biophys Acta. 2009 Apr;1795(2):83-91. doi: 10.1016/j.bbcan.2008.11.001. Epub 2008 Dec 11. Biochim Biophys Acta. 2009. PMID: 19121370 Review.
-
Mitochondrial mutagenesis and oxidative stress in human prostate cancer.J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2004 May;22(1):1-12. doi: 10.1081/GNC-120037931. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2004. PMID: 15845219 Review.
-
Role of oxidative stress response elements and antioxidants in prostate cancer pathobiology and chemoprevention--a mechanistic approach.Curr Med Chem. 2003 Dec;10(24):2679-92. doi: 10.2174/0929867033456341. Curr Med Chem. 2003. PMID: 14529458 Review.
Cited by
-
Inflammation-Associated Cytotoxic Agents in Tumorigenesis.Cancers (Basel). 2023 Dec 22;16(1):81. doi: 10.3390/cancers16010081. Cancers (Basel). 2023. PMID: 38201509 Free PMC article. Review.
-
Androgen receptor contributes to repairing DNA damage induced by inflammation and oxidative stress in prostate cancer.Turk J Biol. 2023 Oct 11;47(5):325-335. doi: 10.55730/1300-0152.2667. eCollection 2023. Turk J Biol. 2023. PMID: 38155939 Free PMC article.
-
Kaempferol Alleviates Mitochondrial Damage by Reducing Mitochondrial Reactive Oxygen Species Production in Lipopolysaccharide-Induced Prostate Organoids.Foods. 2023 Oct 20;12(20):3836. doi: 10.3390/foods12203836. Foods. 2023. PMID: 37893729 Free PMC article.
-
Sigma1 Regulates Lipid Droplet-mediated Redox Homeostasis Required for Prostate Cancer Proliferation.Cancer Res Commun. 2023 Oct 30;3(10):2195-2210. doi: 10.1158/2767-9764.CRC-22-0371. Cancer Res Commun. 2023. PMID: 37874216 Free PMC article.
-
Anti-proliferative effect of Cannabidiol in Prostate cancer cell PC3 is mediated by apoptotic cell death, NFκB activation, increased oxidative stress, and lower reduced glutathione status.PLoS One. 2023 Oct 5;18(10):e0286758. doi: 10.1371/journal.pone.0286758. eCollection 2023. PLoS One. 2023. PMID: 37796968 Free PMC article.
References
-
- Cancer Facts and Figures. American Cancer Society. 2008. URL: http://www.cancer.org/docroot/STT/stt_0.asp.
-
- Huggins C, Hodges CV. Hodges, Studies on Prostatic Cancer. I. The Effect of Castration, of Estrogen and of Androgen Injection on Serum Phosphatases in Metastatic Carcinoma of the Prostate. Cancer Res. 1941;1:293–297. - PubMed
-
- Zoubeidi A, Zardan A, Beraldi E, Fazli L, Sowery R, Rennie P, Nelson C, Gleave M. Cooperative interactions between androgen receptor (AR) and heat-shock protein 27 facilitate AR transcriptional activity. Cancer Res. 2007;67:10455–10465. - PubMed
-
- Isaacs JT. The biology of hormone refractory prostate cancer Why does it develop? Urol. Clin. North Am. 1999;26:263–273. - PubMed
-
- Abate-Shen C, Shen MM. Molecular genetics of prostate cancer. Genes Dev. 2000;14:2410–2434. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials